These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7920069

  • 1. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings.
    Chang WN, Kuriyama M, Chee EC.
    J Formos Med Assoc; 1994 Mar; 93(3):256-9. PubMed ID: 7920069
    [Abstract] [Full Text] [Related]

  • 2. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.
    Kuriyama M, Tokimura Y, Fujiyama J, Utatsu Y, Osame M.
    J Neurol Sci; 1994 Aug; 125(1):22-8. PubMed ID: 7964884
    [Abstract] [Full Text] [Related]

  • 3. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis.
    Kuriyama M, Fujiyama J, Kasama T, Osame M.
    J Lipid Res; 1991 Feb; 32(2):223-9. PubMed ID: 2066659
    [Abstract] [Full Text] [Related]

  • 4. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
    Salen G, Berginer V, Shore V, Horak I, Horak E, Tint GS, Shefer S.
    N Engl J Med; 1987 May 14; 316(20):1233-8. PubMed ID: 3106810
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings.
    Peynet J, Laurent A, De Liege P, Lecoz P, Gambert P, Legrand A, Mikol J, Warnet A.
    Neurology; 1991 Mar 14; 41(3):434-6. PubMed ID: 2006015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Two cases of familial cerebrotendinous xanthomatosis--intrahepatic enzyme assay and therapeutic trial with chenodeoxycholic acid].
    Orimo S, Kobayashi T, Furukawa T, Tsukagoshi H, Kano I.
    Rinsho Shinkeigaku; 1984 Jan 14; 24(1):38-44. PubMed ID: 6467736
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cerebrotendinous xanthomatosis in three siblings from a Chinese family.
    Ko KF, Lee KW.
    Singapore Med J; 2001 Jan 14; 42(1):30-2. PubMed ID: 11361235
    [Abstract] [Full Text] [Related]

  • 18. Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.
    Tint GS, Ginsberg H, Salen G, Le NA, Shefer S.
    J Lipid Res; 1989 May 14; 30(5):633-40. PubMed ID: 2760539
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.
    Wolthers BG, Volmer M, van der Molen J, Koopman BJ, de Jager AE, Waterreus RJ.
    Clin Chim Acta; 1983 Jun 30; 131(1-2):53-65. PubMed ID: 6883710
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.